三葉草生物-B(02197.HK):建議委任先機爲核數師
格隆匯5月19日丨三葉草生物-B(02197.HK)發佈公告,由於與安永會計師事務所(“安永”)就審覈集團截至2025年12月31日止年度的綜合財務報表的審覈費用未能達成共識,董事會建議安永將於其當前任期屆滿後於公司應屆股東周年大會結束時退任公司核數師一職。
董事會已建議委任先機會計師行有限公司(“先機”)爲公司繼安永退任後的新核數師,任期自應屆股東周年大會結束時生效並直至公司下屆股東周年大會結束爲止,惟須經股東於應屆股東周年大會上批準。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.